© 1995 Oxford University Press
research-article |
Inhibition of intestinal tumor development in rat multi-organ carcinogenesis and aberrant crypt foci in rat colon carcinogenesis by 22-oxa-calcitriol, a synthetic analogue of 1
,25-dihydroxyvitamin D3
First Department of Pathology, Osaka City University Medical School 1-4-54 Asahi-machi, Abeno-ku, Osaka 545, Japan
1Second Department of Internal Medicine, Osaka City University Medical School 1-4-54 Asahi-machi, Abeno-ku, Osaka 545, Japan
2Second Department of Biochemistry, Osaka City University Medical School 1-4-54 Asahi-machi, Abeno-ku, Osaka 545, Japan
3To whom correspondence should be addressed
The modifying effects of 22-oxa-calcitriol (OCT), a synthetic analog of 1
,25-dihydroxyvitamin D3, were assessed in a multi-organ carcinogenesis model using male F344 rats initially treated with five kinds of carcinogens. In experiment 1 the rats were given OCT intraperitoneally at doses of 30 µg/kg (25 rats) or 3 µg/kg (25 rats), three times a week for 24 weeks after initial carcinogen exposure over 4 weeks and a 2 week non-treatment period. Twenty-two rats received the five carcinogens and were given the vehicle intraperitoneally as a control. A further group of 10 rats was given the 30 µg/kg dose of OCT without prior carcinogen application. At the end of the total observation period of 30 weeks the carcinoma incidence in the small intestine of rats given 30 µg/kg OCT after carcinogen treatment was 0%. This incidence was significantly smaller when compared with the control group. The incidence of large intestine carcinomas in the 30 µg/kg OCT group showed a tendency to decrease. The numbers of small and large intestinal carcinomas per rat were also significantly lower in the group given 30 µg/kg OCT than after 3 µg/kg OCT or carcinogens alone. Attention was, therefore, focused on colon carcinogenesis and in experiment 2 30 µg/kg OCT administered six times a week to rats for 8 weeks after the last injection of N,N'-dimethylhydrazine (DMH) exposure. OCT significantly reduced the formation of DMH-induced aberrant crypt foci, considered to be putative preneoplastic lesions. In experiment 3 30 µg/kg OCT was administered six times a week to rats for 4 weeks without prior carcinogen treatment. The proliferating cell nuclear antigen labeling index for the colonic epithelium of rats given 30 µg/kg OCT was decreased. Ornithine decarboxylase and spermidine/spermine N1-acetyltransferase activities in colonic epithelium, assayed as indicators of cell proliferation, were not significantly decreased as compared with control group values. Furthermore, vitamin D receptors in colonic epithelium were not significantly increased. Thus the present study indicates that OCT can exert inhibitory effects on tumor development in the small and large intestines, although the mechanism is unclear.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. E. Mullin and A. Dobs Vitamin D and Its Role in Cancer and Immunity: A Prescription for Sunlight Nutr Clin Pract, June 1, 2007; 22(3): 305 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Masuda and G. Jones Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Mol. Cancer Ther., April 1, 2006; 5(4): 797 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Harris and V. L. W. Go Vitamin D and Colon Carcinogenesis J. Nutr., December 1, 2004; 134(12): 3463S - 3471S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Galbiati, L. Polastri, S. Gregori, M. Freschi, M. Casorati, U. Cavallaro, P. Fiorina, F. Bertuzzi, A. Zerbi, G. Pozza, et al. Antitumorigenic and Antiinsulinogenic Effects of Calcitriol on Insulinoma Cells and Solid {beta}-Cell Tumors Endocrinology, October 1, 2002; 143(10): 4018 - 4030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Kim, P. A. Newcomb, C. M. Ulrich, C. L. Keener, J. Bigler, F. M. Farin, R. M. Bostick, and J. D. Potter Vitamin D Receptor Polymorphism and the Risk of Colorectal Adenomas: Evidence of Interaction with Dietary Vitamin D and Calcium Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 869 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fukushima, N. Takada, T. Hori, W. Min, H. Wanibuchi, and S. Yamamoto Suppression of Chemical Carcinogenesis by Water-Soluble Organosulfur Compounds J. Nutr., March 1, 2001; 131(3): 1049S - 1053. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Taniyama, H. Wanibuchi, E. I. Salim, Y. Yano, S. Otani, Y. Nishizawa, H. Morii, and S. Fukushima Chemopreventive effect of 24R,25-dihydroxyvitamin D3 in N,N'-dimethylhydrazine-induced rat colon carcinogenesis Carcinogenesis, February 1, 2000; 21(2): 173 - 178. [Abstract] [Full Text] [PDF]
|
|